PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$10.74
Tradestie Score
56
Market Cap
$871.90M
Revenue Growth
1.0%
Analyst Upside
+120.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SEPN
Septerna, Inc. Common Stock
|
$36.79
|
$847.12M | - | 59 | Compare |
|
XNCR
Xencor, Inc.
|
$12.14
|
$843.75M | - | 64 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$20.64
|
$841.74M | - | 52 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$34.84
|
$832.47M | - | 50 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$30.50
|
$824.20M | - | 62 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.79
|
$821.84M | - | 51 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$39.81
|
$800.41M | - | 57 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$3.95
|
$799.70M | - | 61 | Compare |
|
KURA
Kura Oncology, Inc.
|
$9.56
|
$798.53M | - | 55 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$8.67
|
$791.82M | - | 48 | Compare |
More PHAT Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry